home / stock / lxrx / lxrx news


LXRX News and Press, Lexicon Pharmaceuticals Inc. From 12/09/20

Stock Information

Company Name: Lexicon Pharmaceuticals Inc.
Stock Symbol: LXRX
Market: NASDAQ
Website: lexpharma.com

Menu

LXRX LXRX Quote LXRX Short LXRX News LXRX Articles LXRX Message Board
Get LXRX Alerts

News, Short Squeeze, Breakout and More Instantly...

LXRX - Pelareorep Along With Checkpoint Inhibitors Proving Critically Important for Early Stage Breast Cancer

Palm Beach, FL –December 9, 2020 – In the breast cancer therapy market, the rise in the healthcare awareness among individual’s disease and treatment, early detection of the cancer, better surgical and medical treatment, R&D initiatives, and technological advancemen...

LXRX - IBIO, SFIX, ARCT and LXRX among midday movers

Gainers: Curis (CRIS) +335%.Lexicon Pharmaceuticals (LXRX) +97%.Mammoth Energy Services (TUSK) +61%.NeuroMetrix (NURO) +49%.Stitch Fix (SFIX) +45%.IGM Biosciences (IGMS) +38%.Blonder Tongue Laboratories (BDR) +26%.Infinity Pharmaceuticals (INFI) +25%.KLX Energy Services (KLXE) +24%....

LXRX - Are These Biotech Penny Stocks To Buy Before 2021? 3 Names To Know

Biotech Penny Stocks To Watch Before The New Year This week was more than just a big week for penny stocks . Several sectors and broader markets in general, reached new all-time highs. Now, not only did we see things like the S&P and Dow mirror that, but we also saw the Russell ...

LXRX - Citi upgrade Lifts Lexicon Pharma by 38%

Lexicon Pharmaceuticals (NASDAQ:LXRX) surges +38.2% in pre-market trading after Citi raised its rating from Neutral to Buy.Amid collaboration chatter, the stock “should regain momentum” noted the analyst Yigal Nochomovitz as partnership talks continue after an exp...

LXRX - SFIX, AR among premarket gainers

Curis CRIS +199% on encouraging CA-4948 data in leukemia.NeuroMetrix (NURO) +84%.Stitch Fix SFIX +39% on Q1 results.Lexicon Pharmaceuticals (LXRX) +31%.Cancer Genetics (CGIX) +28%.Smartsheet SMAR +18% on Q3 results.Tarena TEDU +18% on founder's going pr...

LXRX - KNDI, RIOT, IBIO and GDRX among midday movers

Gainers: Phoenix Tree (DNK) +65%.Lexicon Pharmaceuticals (LXRX) +43%.Riot Blockchain (RIOT) +40%.Zomedica Pharmaceuticals (ZOM) +33%.Miragen Therapeutics (MGEN) +28%.AXT (AXTI) +27%.Glory Star New Media Group (GSMG) +26%.Yunhong CTI (CTIB) +23%.Kandi Technologies (KNDI) +22%.Se...

LXRX - Lexicon Pharmaceuticals, Zomedica Pharmaceuticals leads healthcare gainers; Brainstorm Cell Therapeutics, GoodRx Holdings among losers

Gainers: Lexicon Pharmaceuticals (LXRX) +45%, Zomedica Pharmaceuticals (ZOM) +33%, Miragen Therapeutics (MGEN) +17%, SQZ Biotechnologies (SQZ) +15%, PLx Pharma (PLXP) +13%.Losers: Brainstorm Cell Therapeutics (BCLI) -67%, GoodRx Holdings (GDRX) ...

LXRX - TSLA, YY, VLDR and TOUR among premarket gainers

Lexicon Pharmaceuticals (LXRX) +49% after its drug shows benefits for heart patients.Yunhong CTI (CTIB) +43%.Mogo (MOGO) +42% after entering agreement to acquire Carta Worldwide.Sequential Brands Group (SQBG) +36% on Q3 results.Golden Bull Limited (BTBT) +19%.Com...

LXRX - Lexicon Pharma +45% after drug shows benefits for heart patients

Lexicon Pharmaceuticals (LXRX) soars as much as 80% pre-market after saying two Phase 3 studies achieved their primary endpoints by showing statistically significant reductions in cardiovascular deaths, hospitalizations for heart failure and urgent heart failure visits in patients treated wit...

LXRX - Results From SOLOIST and SCORED Outcomes Studies Presented at Late-Breaking Science Session of American Heart Association Scientific Sessions and Published in The New England Journal of Medicine

THE WOODLANDS, Texas, Nov. 16, 2020 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX), today announced that both the SOLOIST and SCORED Phase 3 studies achieved their primary endpoints by demonstrating statistically significant reductions in total cardiovascular death...

Previous 10 Next 10